Dietary Supplementation with Nondigestible Oligosaccharides Reduces Allergic Symptoms and Supports Low Dose Oral Immunotherapy in a Peanut Allergy Mouse Model

SCOPE: A major downside of oral immunotherapy (OIT) for food allergy is the risk of severe side effects. Non‐digestible short‐ and long‐chain fructo‐oligosaccharides (scFOS/lcFOS) reduce allergy development in murine models. Therefore, it is hypothesized that scFOS/lcFOS can also support the efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagenaar, Laura, Bol‐Schoenmakers, Marianne, Giustarini, Giulio, Vonk, Marlotte M., van Esch, Betty C.A.M., Knippels, Leon M.J., Garssen, Johan, Smit, Joost J., Pieters, Raymond H.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766954/
https://www.ncbi.nlm.nih.gov/pubmed/30102006
http://dx.doi.org/10.1002/mnfr.201800369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766954/
https://www.ncbi.nlm.nih.gov/pubmed/30102006
http://dx.doi.org/10.1002/mnfr.201800369

Ejemplares similares